In addition to GLP-1R/GCGR dual agonists, a chimeric peptide as dual GLP-1/GIP receptor agonists has been developed, showing enhanced therapeutic potential for obesity and related comorbidities
Continuous enrollment requirements might introduce immortal time bias as outcomes for patients with less than 12 months of follow-up are not included, and selection bias might arise from including only patients with available laboratory results and EHRs
Unlike the body's own -MSH, which has a half-life of only about 10 minutes and breaks down quickly, Melanotan II was engineered for stability and prolonged activity
Aggrephagy: selective disposal of protein aggregates by macroautophagy
THP-1, U2OS and Jurkat cells were stained with 1:100 FITC Annexin V (BioLegend, 640906) and 1:1,000 7-AAD (BioLegend, 420403)
Why take NAC instead of glutathione